The iLCT Pipeline Research Acceleration Programme is a targeted funding call launched by Cure Parkinson’s to accelerate high-priority therapeutic candidates toward clinical trials for Parkinson’s disease.

This programme forms part of the International Linked Clinical Trials (iLCT) initiative, a global drug selection and evaluation platform established in collaboration with the Van Andel Institute. The iLCT committee comprising over 20 world-leading Parkinson’s experts annually reviews and ranks candidate compounds with disease-modifying potential.

The Nkulo Community Partnership Trust has issued a Call for Proposals inviting impactful, community-centred projects that create sustainable social and economic value in communities connected to Thungela operations and designated labour-sending areas.

The Trust seeks to partner with organisations delivering measurable, long-term outcomes in areas that strengthen local resilience, economic participation and community wellbeing.

This call prioritises initiatives that:

The Brücke Le Pont Pilot Project on Labour Rights and Decent Working Conditions in Ghana is a new funding opportunity for a Ghana‑based civil society organisation to design and implement a 12‑month pilot project improving labour rights and working conditions for agricultural workers, with a view to a long‑term (up to 10–12 year) partnership. The initiative focuses on systemic, market‑based change in agricultural value chains, using a Market Systems Development (MSD) approach rather than one‑off service delivery, and offers up to CHF 50,000 (approx.

TÜBİTAK (Türkiye) and CNPq (Brazil) have launched a bilateral research call to fund joint projects that generate new scientific knowledge, innovative interpretations, and solutions to technological challenges in key areas including environment, food and agriculture, health, ICT and physics, with a submission deadline of 4 May 2026.

The Technology Innovation Agency (TIA), South Africa, and BioCubaFarma (BCF), Cuba, have extended their joint Expression of Interest (EOI): South Africa–Cuba Biotechnology Collaboration to Friday, 27 February 2026. This EOI seeks South African partners to collaborate with Cuban institutions on technology transfer, joint development, and joint ventures for innovative biotech products, with a strong focus on therapies for neurodegenerative and chronic diseases such as Parkinson’s disease, Multiple Sclerosis, Dementia, lung cancer, and Alzheimer’s Disease.

The Novo Nordisk Foundation Pioneer Innovator Grant Programme 2026 supports early‑stage academic research projects in health and sustainability with clear commercial and societal impact potential, offering up to DKK 1.2 million over one year per project.​

Opportunity overview

The Xiamen BRICS Cross‑Border Innovation Accelerator Program 2026 is a flagship international acceleration initiative hosted in Xiamen, China, designed to help high‑potential overseas and China‑based innovation companies enter, validate and scale in the Chinese market.